Trials / Sponsors / Fresenius Kabi, France
Fresenius Kabi, France
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a B Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis | — | 2022-11-24 |